Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Mediators of Inflammation|May 8, 2014
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsisJ Sardinha, M E M Kelly, J Zhou, et al.British Journal of Pharmacology|August 14, 2013
Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRsH J Dranse, M E M Kelly, B D HudsonBritish Journal of Pharmacology|August 29, 2012
The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcriptionR B Laprairie, M E M Kelly, E M Denovan-WrightClinical Hemorheology and Microcirculation|October 12, 2013
Leukocyte-endothelial interactions within the ocular microcirculation in inflammation and infectionN A Al-Banna, J T Toguri, M E M Kelly, et al.British Journal of Pharmacology|July 29, 2015
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptorR B Laprairie, A M Bagher, M E M Kelly, et al.Medical Hypotheses|April 8, 2014
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndromeC Lehmann, I Burkovskiy, J Kuethe, et al.British Journal of Pharmacology|October 9, 2007
Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cellsB T McIntosh, B Hudson, S Yegorova, et al.Clinical Hemorheology and Microcirculation|September 28, 2015
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammationJ T Toguri, R Moxsom, A M Szczesniak, et al.Neuroscience|May 9, 2006
Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cellsG E Bertolesi, R Walia Da Silva, C A B Jollimore, et al.British Journal of Pharmacology|December 7, 2013
Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitisJ T Toguri, C Lehmann, R B Laprairie, et al.Pageof 2